AETHLON MEDICAL INC (AEMD) Stock Price, Forecast & Analysis
NASDAQ:AEMD • US00808Y6041
AEMD Key Statistics, Chart & Performance
The current stock price of AEMD is 1.98 USD. In the past month the price decreased by -24.28%. In the past year, price decreased by -95.98%.
AEMD Technical Analysis
AEMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AEMD. While AEMD seems to be doing ok healthwise, there are quite some concerns on its profitability.
AEMD Financial Highlights
Over the last trailing twelve months AEMD reported a non-GAAP Earnings per Share(EPS) of -102.34. The EPS increased by 54.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -153.74% | ||
| ROE | -195.94% | ||
| Debt/Equity | 0 |
AEMD Forecast & Estimates
7 analysts have analysed AEMD and the average price target is 12.62 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.98.
AEMD Ownership
AEMD Latest News, Press Relases and Analysis
AEMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.41 | 197.518B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.82 | 175.875B | ||
| SYK | STRYKER CORP | 24.2 | 139.086B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.16 | 108.957B | ||
| IDXX | IDEXX LABORATORIES INC | 41.66 | 51.801B | ||
| BDX | BECTON DICKINSON AND CO | 11.28 | 51.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.71 | 46.035B | ||
| RMD | RESMED INC | 20.01 | 37.897B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.66 | 36.095B | ||
| DXCM | DEXCOM INC | 25.78 | 26.58B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AEMD
Company Profile
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The firm is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.
Company Info
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123 US
CEO: Charles J. Fisher Jr
Employees: 9
Phone: 16199410360
AETHLON MEDICAL INC / AEMD FAQ
Can you describe the business of AETHLON MEDICAL INC?
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The firm is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.
Can you provide the latest stock price for AETHLON MEDICAL INC?
The current stock price of AEMD is 1.98 USD. The price decreased by -5.26% in the last trading session.
What is the dividend status of AETHLON MEDICAL INC?
AEMD does not pay a dividend.
What is the ChartMill rating of AETHLON MEDICAL INC stock?
AEMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of AEMD stock?
AETHLON MEDICAL INC (AEMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of AEMD stock?
AETHLON MEDICAL INC (AEMD) has a market capitalization of 1.92M USD. This makes AEMD a Nano Cap stock.